Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of Asasantin ER in Healthy Japanese Males
NCT02273479Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 1999
- Primary completion
- Sep 1999
- Modality
- Small Molecules, Drug Delivery Systems
01
Overview
Phase 1, randomised, double-blind trial in stroke comparing Asasantin with Placebo (2 arms). Primary endpoints: Area under the plasma drug concentration-time curve at steady state up to 144 hours, Maximum drug plasma concentration at steady state up to 144 hours and 6 more. Started Jul 1999; status: completed.
02
Drugs
dipyridamole + aspirin
03
Conditions
stroke
Beyond the preview
Go deeper on NCT02273479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02273479.